Cresset Asset Management, LLC Hcw Biologics Inc. Transaction History
Cresset Asset Management, LLC
- $25.6 Billion
- Q3 2024
A detailed history of Cresset Asset Management, LLC transactions in Hcw Biologics Inc. stock. As of the latest transaction made, Cresset Asset Management, LLC holds 131,990 shares of HCWB stock, worth $54,115. This represents 0.0% of its overall portfolio holdings.
Number of Shares
131,990
Previous 131,990
-0.0%
Holding current value
$54,115
Previous $85,000
16.47%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding HCWB
# of Institutions
17Shares Held
1.16MCall Options Held
0Put Options Held
0-
Avantax Planning Partners, Inc.280KShares$114,6110.01% of portfolio
-
Geode Capital Management, LLC Boston, MA183KShares$75,1360.0% of portfolio
-
High Tower Advisors, LLC Chicago, IL181KShares$74,1320.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX84.7KShares$34,7270.0% of portfolio
-
Pullen Investment Management, LLC Bradenton, FL75.1KShares$30,7970.03% of portfolio
About HCW Biologics Inc.
- Ticker HCWB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,833,100
- Market Cap $14.7M
- Description
- HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal...